Seller record · Telehealth service

Tru2u

Fails 3 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The home page refers to a partner pharmacy and the product pages to FDA-registered pharmacies in the United States. 2 more criteria also fail; see the table below.

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A women's wellness store selling its own supplement line alongside compounded semaglutide and tirzepatide injections and tablets, a semaglutide and tirzepatide blend, NAD+ injections, and prescription skin and hair treatments, with prescribing by an outside clinical partner. Its product pages call every treatment FDA-approved, and no pharmacy is named.

Operating entity No legal entity name appears in the footer, in the terms and conditions, in the privacy policy or in the refund and shipping policies; the terms say only that the business is incorporated in Oregon, and the store's terms of service end with unfilled placeholders for the trading name and address.

Dispositions

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, compounded oral semaglutide tablets, compounded oral tirzepatide tablets, GLP Squared (semaglutide + tirzepatide), NAD+ injection, sildenafil, prescription skin and hair treatments, supplements.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.